Extended Antibiotic Prophylaxis Not Beneficial After Postmastectomy Breast Reconstruction
FRIDAY, May 19, 2023 (HealthDay News) — For patients undergoing postmastectomy breast reconstruction (PMBR), extended antibiotic prophylaxis (EAP) does not prevent infection, admission, reoperation, or explantation rates, according to a study publish…
Learn MoreEl virus de la viruela símica se puede replicar durante días en las superficies, según un estudio
JUEVES, 18 de mayo de 2023 (HealthDay News) — La mayoría de los casos de viruela símica se propagan a través del contacto de piel con piel, pero es posible contraer el virus mediante el contacto con una superficie contaminada en una vivienda o en una…
Learn MoreUn panel de la FDA votará sobre la primera vacuna contra el VSR en el embarazo para proteger a los bebés
JUEVES, 18 de mayo de 2023 (HealthDay News) — Un panel de asesores de la Administración de Alimentos y Medicamentos (FDA) de EE. UU. está evaluando la primera vacuna contra el VSR diseñada para proteger a los bebés.Un comité de expertos independiente…
Learn MoreNew Clues to Why Some People Suppress HIV Without Drugs
FRIDAY, May 19, 2023 (HealthDay News) — Some HIV patients are naturally able to keep the virus fully in check without any medicinal help, a phenomenon that has intrigued scientists for decades.New research appears to identify at least one reason why:…
Learn MoreJYNNEOS Vaccine Seems Effective for Preventing Mpox
FRIDAY, May 19, 2023 (HealthDay News) — The JYNNEOS vaccine seems to be effective for preventing mpox disease, with better protection conferred from a two-dose series, according to a study published online May 18 in the New England Journal of Medicin…
Learn MoreFDA Panel Backs First RSV Vaccine Given in Pregnancy to Protect Infants
THURSDAY, May 18, 2023 (HealthDay News) — The first vaccine designed to protect infants against respiratory syncytial virus (RSV) by vaccinating their mothers during pregnancy has been backed by a panel of advisers to the U.S. Food and Drug Administr…
Learn MoreFDA Panel Recommends Approval of First RSV Vaccine Given in Pregnancy to Protect Infants
THURSDAY, May 18, 2023 (HealthDay News) — A panel of advisers to the U.S. Food and Drug Administration voted Thursday to recommend the first respiratory syncytial virus (RSV) vaccine designed to protect infants.The independent committee of experts vo…
Learn MoreHeart Transplant Survival Affected With COVID-19-Positive Donor Organs
THURSDAY, May 18, 2023 (HealthDay News) — Heart transplant (HT) recipients from donors with active COVID-19 have increased mortality at six months and one year, while survival is similar for recently resolved COVID-19 donors and non-COVID-19 donors, …
Learn MorePreexisting OSA Linked to Odds of Postacute Sequelae of SARS-CoV-2
THURSDAY, May 18, 2023 (HealthDay News) — Preexisting obstructive sleep apnea (OSA) is associated with increased odds of probable postacute sequelae of severe acute respiratory syndrome coronavirus 2 (PASC), according to a study published online May …
Learn MoreFDA Panel to Vote on First RSV Vaccine Given in Pregnancy to Protect Infants
THURSDAY, May 18, 2023 (HealthDay News) — The first RSV vaccine designed to protect infants is under consideration by a panel of advisers to the U.S. Food and Drug Administration.An independent committee of experts will vote Thursday on whether to re…
Learn More